Status:
COMPLETED
Use of ST250 to Reconstruct Lateral Tongue Defects
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Marienhospital Stuttgart
Conditions:
Tongue Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane is applied to reconstruct lateral tongue defects . healing of the mucosa and regaining of normal ...
Detailed Description
Lateral tongue defects are usually treated using radial fore-arm free grafts which require a prolonged hospital stay with higher morbidity rates. It also entails the need of multiple rehabilitation an...
Eligibility Criteria
Inclusion
- lateral tunge defects (postoncologic resection)
Exclusion
- radio / chemotherapy
- pregnant/ breastfeeding women
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06988449
Start Date
July 1 2022
End Date
March 30 2025
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MarienHospital
Stuttgart, Baden-Wurttemberg, Germany